Addressing Clinicians’ Challenges and Misinformation Around Diagnosis of Alzheimer Disease episode artwork

EPISODE · Sep 20, 2022 · 13 MIN

Addressing Clinicians’ Challenges and Misinformation Around Diagnosis of Alzheimer Disease

from Pri-Med Podcasts · host Pri-Med

Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/Podcast/alzheimer-disease-addressing-challenges-pt1 Overview: Alzheimer disease (AD) is a growing concern as the population ages. Primary care clinicians are often the first to screen for and identify signs of cognitive impairment which may be due to AD. Join neurologist Gad Marshall, MD in this two-part podcast series, as he answers important questions and provides helpful tips for assessing cognitive impairment in primary care and provides insight into the current and emerging role of neuroimaging and biomarkers in the diagnosis of AD. The topics covered in this podcast are based on challenges and misconceptions identified from the CME/CE curriculum The Future of Alzheimer Disease: Early Recognition and Emerging Therapy.

Episode metadata supplied by the publisher feed · Published Sep 20, 2022

Embed this episode

NOW PLAYING

Addressing Clinicians’ Challenges and Misinformation Around Diagnosis of Alzheimer Disease

0:00 13:19

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Pri-Med Podcasts?

This episode is 13 minutes long.

When was this Pri-Med Podcasts episode published?

This episode was published on September 20, 2022.

Can I download this Pri-Med Podcasts episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!